Use this DSCSA 2026 checklist to strengthen EPCIS data exchange, exception handling, partner onboarding, and operational readiness.
Blog
Whitepaper: NDC12 – Revising the National Drug Code Format and Drug Label Barcode Requirements for the U.S. Market
This white paper blends the original high-level summary with a more detailed narrative, offering both clear structure and practical depth. It explains the new NDC format, explores stakeholder impacts, describes the implications for GTIN, and outlines concrete next steps and emerging solution options.
Digital Factory Maturity in Pharma: How to Build a Practical Roadmap
Learn how pharma manufacturers can assess digital factory maturity, prioritize transformation projects, improve data visibility, and build a practical 2026 roadmap.
Hyperautomation Hits Pharma: Merging RPA and AI for End-to-End Supply Chain Efficiency
This blog post will explore the power of hyperautomation, its most impactful applications, and the strategic guidance needed to navigate the inevitable workforce and cultural shifts, highlighting quick wins that many competitors overlook.
Reshoring and Nearshoring: Rebuilding Pharma Supply Chains for Localization and Resilience
For decades, the global pharmaceutical industry operated on a model of maximum efficiency, often driven by the pursuit of the lowest cost. This led to a highly complex, geographically dispersed pharma supply chain, with raw material suppliers, API (Active Pharmaceutical Ingredient) manufacturers, and drug packagers often located thousands of miles...
